Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review
Journal of Affective Disorders · 2025-01 · 368 · 798-819
DOI: 10.1016/j.jad.2024.09.081 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Affective Disorders, 2025-01. Verfasst von Gia Han Le und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Mood Disorder Psychopharmacology Unit, University Health Network, Toro…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Electroencephalography, Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Converging evidence suggests electroencephalography (EEG) methods may elucidate alterations in global structural and functional connectivity that underlie the pathophysiology of depressive disorders. Extant literature suggests SSRIs and SNRIs may broadly induce alterations to EEG-measured neural activity. Herein, this systematic review comprehensively evaluates changes to EEG spectral signatures associated with vortioxetine and each FDA-approved agent within the SSRI and SNRI class. METHODS: We conducted a systematic review of studies investigating changes to EEG spectral signatures associated with SSRI, SNRI, and/or vortioxetine treatment in persons with MDD. Database search occurred from database inception to May 3, 2024. RESULTS: Our search yielded 15 studies investigating overall spectral signature changes associated with SSRI- and/or SNRI-treatment. The existing literature presents with mixed findings. Notwithstanding, we did observe a pattern in which the SSRI and SNRI agents reproducibly affect EEG spectral signatures. We observed overlapping yet distinct spectral patterns for each agent within- and between-drug classes of SSRIs and SNRIs. Changes in resting/wake EEG were also observed. LIMITATIONS: The findings from our systematic review are mixed. Heterogeneity exists with sample size, composition, dosing of antidepressants, duration of antidepressant exposure, as well as the type of EEG devices used. DISCUSSIONS: Our findings provide support to the notion that although SSRIs, SNRIs and vortioxetine block reuptake of the serotonin transporter; they are different in their profile of pharmacology as evidenced by differential EEG signatures. EEG changes associated with SSRIs, SNRIs and vortioxetine are also highly replicated findings across mixed studies and populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toront…
- Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of To…
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Psychology, University of Western Ontario, London, Ontario, Canada. Electronic address: alu96@uwo.ca.
- Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. Electronic address: shreya.vasudeva@mail.utoronto.ca.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. Electronic address: hartej.gill@utoronto.ca.
- Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. Electronic address: daylen.rodriguezportelles@mail.utoronto.ca.
Zitieren
APA
Le, G. H., Wong, S., Lu, A., Vasudeva, S., Gill, H., Badulescu, S., Portelles, D. R., Zheng, Y. J., Teopiz, K. M., Meshkat, S., Kwan, A. T. H., Ho, R., Rhee, T. G., Rosenblat, J. D., Mansur, R. B., & McIntyre, R. S. (2025). Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review. Journal of Affective Disorders, 368, 798-819. https://doi.org/10.1016/j.jad.2024.09.081
Vancouver
Le GH, Wong S, Lu A, Vasudeva S, Gill H, Badulescu S, et al. Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review. Journal of Affective Disorders. 2025;368:798-819. doi:10.1016/j.jad.2024.09.081
BibTeX
@article{Le2025,
author = {Le, Gia Han and Wong, Sabrina and Lu, Andy and Vasudeva, Shreya and Gill, Hartej and Badulescu, Sebastian and Portelles, Daylen Rodriguez and Zheng, Yang Jing and Teopiz, Kayla M and Meshkat, Shakila and Kwan, Angela T H and Ho, Roger and Rhee, Taeho Greg and Rosenblat, Joshua D and Mansur, Rodrigo B and McIntyre, Roger S},
title = {Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review},
journal = {Journal of Affective Disorders},
year = {2025},
volume = {368},
pages = {798--819},
doi = {10.1016/j.jad.2024.09.081}
}
EUVIMED